Identification of Novel ERK2 Substrates through Use of an Engineered Kinase and ATP Analogs
Scott T. Eblen(University of Virginia), Michael J. Weber(Carter Center), Colin Watts(Garvan Institute of Medical Research), Kevan M. Shokat(Howard Hughes Medical Institute), N. Vinay Kumar(University of Virginia), Kavita Shah(Purdue University West Lafayette), Michelle J. Henderson(New South Wales Department of Health)
Cited by 121
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k